EP0948262A1 - Sauermilchprodukt - Google Patents

Sauermilchprodukt

Info

Publication number
EP0948262A1
EP0948262A1 EP97951127A EP97951127A EP0948262A1 EP 0948262 A1 EP0948262 A1 EP 0948262A1 EP 97951127 A EP97951127 A EP 97951127A EP 97951127 A EP97951127 A EP 97951127A EP 0948262 A1 EP0948262 A1 EP 0948262A1
Authority
EP
European Patent Office
Prior art keywords
milk
redox potential
lactic acid
fermented
acid bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97951127A
Other languages
English (en)
French (fr)
Inventor
Rodney Stuart Moreton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Priority to EP97951127A priority Critical patent/EP0948262A1/de
Publication of EP0948262A1 publication Critical patent/EP0948262A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.

Definitions

  • the subject of the present invention is a new process for preparing a fermented milk composition, said process making it possible to obtain food compositions having a particularly high load of lactic acid bacteria, even after packaging and preservation for prolonged periods.
  • lactic acid bacteria are generally known to have beneficial effects on human health, only certain categories of lactic acid bacteria are actually able to adhere to human intestinal cells, to exclude pathogenic bacteria on human intestinal cells, and / or act on the human immune system by allowing it to react more strongly to external aggressions. Lactic acid bacteria are said to be "probiotic" when they have at least one of these characteristics.
  • lactic acid bacteria are truly probiotic bacteria.
  • the strains Lactobacillus casei ATCC53103, Lactobacillus acidophilus CNCM 1-1225, Bifidobacterium breve CNCM 1-1226, Bifidobacterium infantis CNCM 1-1227 and Bifidobacteriun longum CNCM 1-1228 have thus been scientifically recognized as probiotic bacteria in the measurement where they are able to adhere to human intestinal cells, to exclude pathogenic bacteria on human intestinal cells, and to act on the human immune system (EP577904; EP577903; EPI 99535; Gut, 3_5_, 483-489, 1994 ; J. of Dairy Science, 7_8_, 491-197, 1995; Applied Env. Microb., £ 9_, 4121-4128, 1993).
  • Probiotic lactic acid bacteria are often also extremely sensitive to oxygen, due to their adaptation to the anaerobic living conditions found in the intestinal tract. In addition, these bacteria grow poorly in milk, which poses problems in achieving a sufficient level of lactic acid bacteria in a fermented milk product.
  • EPI 54614 suggests increasing the charge of the starter culture when sowing milk, and also adding growth stimulants, such as extracts, to this milk. yeast or whey protein, for example.
  • the present invention aims to overcome the drawbacks of the prior art, by providing a process which promotes the survival of lactic acid bacteria.
  • the present invention relates to a process for manufacturing a fermented milk composition in which milk is heat treated at a temperature and for a time such that its redox potential at 25 ° C is lowered to a value less than 450 mvolt, and the milk is inoculated with lactic acid bacteria.
  • the present invention also covers all dairy compositions packaged in an impermeable or semi-permeable oxygen material, said compositions comprising at least 10 6 cfii / ml of probiotic lactic acid bacteria and a redox potential of less than 450 mvolt (cfu comes from l 'English expression "colony forming unit").
  • the invention also relates to the use of a milk having a redox potential at 25 ° C. which is less than 450 mvolt, for the preparation of a dairy product comprising lactic acid bacteria.
  • the invention also relates to the use of a fermented milk composition resulting from the present process in the preparation of a dairy product comprising lactic acid bacteria.
  • lactic acid bacteria which are known to be sensitive to the conditions of fermentation and storage of a milk, for example sensitive to the presence of air, in fact become more resistant to these conditions, and in particular become tolerant to presence of air, as soon as the redox potential of the milk in which they live is less than about 450 mvolt. This resistance results in better bacterial development during the fermentation of milk, and better survival of bacteria during the conservation of fermented milk.
  • this redox potential can be adjusted by various means, it has been found that prolonged pasteurization of milk is sufficient to achieve a required redox potential. Indeed, a prolonged heat treatment makes it possible to break certain proteins in milk and thus to release reducing groups. In addition, this treatment makes it possible to react the proteins and sugars of the milk so that it forms reducing compounds resulting from Maillard reactions.
  • This pasteurization has other advantages. Firstly, prolonged treatment of milk at high temperatures promotes degassing of the milk, and therefore a low oxygen content in the milk. Second, this treatment converts part of the lactose in milk to lactulose, which is known to stimulate the growth of certain lactic acid bacteria.
  • - Figure 1 shows, after fermentation, the number of cells of the strain CNCM 1-1225 (cfu / ml) having grown in different milks, said milks having undergone different heat treatments before fermentation, said fermented milks having been kept for 1 or 28 days at refrigeration temperatures, and said fermented milks having also been packaged in glass or polystyrene packaging.
  • - Figure 2 shows, after fermentation, the number of cells of the strain CNCM 1-1225 (cfu / ml) having grown in different milks, said milks having a redox potential of the order of 500 mvolt or -50 mvolt before fermentation , and said fermentation being carried out under aerobic or anaerobic conditions.
  • Figure 3 represents the number of cells of the strain CNCM 1-1225 (cfu / ml) having grown in different milks, as well as the redox potential at 25 ° C of these fermented milks, as a function of the storage time of these milks ferments at refrigeration temperatures.
  • rennet is given to the coagulating extract coming from abomasum of young ruminants slaughtered before weaning. It will be recognized that rennet also includes veal rennet substitutes, such as animal pepsins; coagulating preparations from the plant kingdom extracted from artichoke, thistle, ficin, latex, fig, papain, for example; coagulating preparations from the microbial kingdom extracted from bacteria of the genus Bacillus and Pseudomonas, and molds belonging to the species Endothia parasitica, Mucor pusillus and Mucor miehei, for example.
  • veal rennet substitutes such as animal pepsins
  • milk is meant, on the one hand, a milk of animal origin, such as milk from cows, goats, sheep, buflesse, zebu, mare, donkey, camel, etc.
  • This milk may be a milk in the native state, a reconstituted milk, a skimmed milk, or a milk supplemented with compounds necessary for the growth of bacteria or for the treatment of milk such as fats, yeast extract, peptone, ascorbic acid and / or a surfactant, for example.
  • these milks have a pH of the order of 6.4-7, in particular pH 6.6-6.8.
  • milk also applies to what is commonly called vegetable milk, that is to say an extract of plant materials treated or not, such as legumes (soy, chickpea, lentil, ect ...) or oilseeds (rapeseed, soya, sesame, cotton, ect %), extract which contains proteins in solution or in colloidal suspension, coagulable by chemical action, by acid fermentation and / or by heat.
  • vegetable milks could undergo heat treatments analogous to those of animal milks. They may also have had their own treatments, such as discoloration, deodorization, and treatments for removing unwanted taste.
  • the word milk also designates mixtures of animal milks and vegetable milks.
  • these milks Preferably, these milks have a pH of the order of 6.4-7, in particular pH 6.6-6.8.
  • the growth and survival of certain lactic acid bacteria are also influenced by the milk water activity (Aw), that is to say by the ratio between the partial vapor pressure of the water on the surface of the powder and the vapor pressure of pure water at the same temperature.
  • Aw milk water activity
  • the Aw can be determined by measuring the relative equilibrium humidity reached in a closed enclosure at constant temperature. For this, a sample of a few g of milk is enclosed in a sealed container placed in a room thermostatically controlled at 20 ° C. The empty space around this sample reaches equilibrium, after 30-60 min, the same Aw value as the sample.
  • An electronic sensor mounted in the closure lid of the container, then measures the humidity of this empty space by means of an electrolytic resistance.
  • the addition of at least one agent which promotes bacterial growth in milk makes it possible to significantly enhance the growth and survival of certain lactic acid bacteria.
  • these agents there may in particular be a sugar such as glucose and sucrose, an amino acid such as cysteine and glutathione, a yeast extract in particular an extract comprising large amounts of purine and pyrimidine bases as well as their phosphate derivatives (adenosine , thymine, guanine, cytosine and uracil) and / or hydrolysates of animal or vegetable protein materials (soy), for example.
  • the milk can comprise approximately 0.1-1% of yeast extract and / or approximately 0.25-1% of peptones.
  • All the devices intended for pasteurizing milk can be used by a person skilled in the art. It is thus possible to heat treat milk at least 90 ° C for at least 30 min, preferably at 95-130 ° C for 30-120 min, so as to obtain a redox potential of less than 450 mvolt, in particular less than 400 mvolt, or even less than 350 mvolt if one wants to obtain maximum growth and survival of lactic acid bacteria, for example.
  • the pasteurized milk is inoculated with at least one strain of lactic acid bacteria so as to obtain directly in the milk from 10 3 to 10 8 cfu / ml.
  • the milk can be inoculated with a culture of fresh lactic acid bacteria, with a concentrated and frozen culture, or even with a culture dried by lyophilization or by spraying under a flow of hot air (see US389730), for example.
  • the strain of lactic acid bacteria can be chosen from the Lactococcus lactis species, in particular L. lactis subsp. cremoris, L. lactis subsp. lactic biovar diacetylactis, and L. lactis; Streptococcus thermophilus; acidophilic bacteria including L. acidophilus, L. crispatus, L. amylovorous, L. gallinarum, L. gasseri, L. johnsonii; Lactobacillus fermentum; Lactobacillus casei including L. casei subsp. casei; Lactobacillus delbruckii, in particular L. delbruckii subsp lactis; L. delbruckii subsp.
  • lactic acid bacteria which are sensitive to oxygen are used, in particular all bifidobacteria, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus bulgaricus and Lactobacillus helveticus.
  • Probiotic bacteria are of particular interest in the context of the present invention. These bacteria are in fact capable of adhering to human intestinal cells, of excluding pathogenic bacteria on human intestinal cells, and of acting on the human immune system by allowing it to react more strongly to external aggressions (ability to immunomodulation), for example by increasing the phagocytosis capacities of granulocytes derived from human blood (J. of Dairy Science, 7 £, 491-197, 1995: immunomodulation capacity of the strain La-1 which has been deposited at the Institut Pasteur under the number CNCM 1-1225).
  • Lactobacillus acidophilus CNCM I-1225 strain described in EP577904 can be used.
  • This strain was recently reclassified among Lactobacillus johnsonii, following the new taxonomy, proposed by Fujisawa et al, which is now an authority on the taxonomy of acidophilic lactobacilli (Int. J. Syst. Bact., 42, 487-791, 1992).
  • Other probiotic bacteria are also available, such as those described in EPI 99535 (Gorbach et al.) Or in US5296221 (Mitsuoka et al.), For example.
  • the dairy composition obtained by the process according to the invention can also be traditionally fermented until at least 10 6 cfu / ml, in particular 10? -10 9 cfu / ml, for example, are obtained.
  • these milk compositions comprise probiotic lactic acid bacteria, in particular the strain L. johnsonii CNCM 1-1225, it is preferable to carry out the fermentation in the absence of oxygen, for example under an atmosphere of carbon dioxide.
  • the milk composition obtained by the process according to the invention can also be transformed into unripened fresh cheeses which are commonly called in Anglo-Saxon countries “quarg” or “cottage-cheese” and in Germany “quark”, by example.
  • the milk inoculated with lactic acid bacteria can be fermented, but not necessarily. Rennet is generally added to it, of the order of 0.01 to 0.15% by volume / volume, so as to pass the casein from one phase colloidal to a precipitated phase, this passage being accompanied by the formation of a whey. Then, the whey is separated by centrifugation or ultrafiltration.
  • the invention also covers all dairy compositions packaged in an impermeable or semi-permeable oxygen material, said compositions comprising at least 10 6 cfu / ml of probiotic lactic acid bacteria and a redox potential of less than 450 mvolt, preferably less than 400-350 mvolt if one wants compositions in which the viability of lactic acid bacteria is stabilized at an acceptable level
  • the dairy compositions according to the invention are packaged in a material which allows less than 0.01 cm 3 of air to pass per day and per cm 2 under an external pressure of 0.21 bar, for example a material impermeable to air like glass or ethyl vinyl alcohol (EVOH), or a semi-permeable material like polystyrene (PS), polypropylene (PP), polyethylene terepthalate (PET), ethyl vinyl alcohol (EVOH), high density polyethylene (HDPE), or a mixture of these materials, for example.
  • a material impermeable to air like glass or ethyl vinyl alcohol (EVOH), or a semi-permeable material like polystyrene (PS), polypropylene (PP), polyethylene terepthalate (PET), ethyl vinyl alcohol (EVOH), high density polyethylene (HDPE), or a mixture of these materials, for example.
  • a material impermeable to air like glass or ethyl vinyl alcohol (EVOH), or a semi
  • the milk composition obtained by the present process can also be used to prepare other fermented milk products, in particular as starter for large-scale milk fermentation, for example.
  • the measurement of the redox potential is carried out in accordance with the publication by Buhler H. et al. (Ingold AG, Germany). For this, a pH / mvolt meter is used combined with a redox electrode (Ingold n ° 105053288). The pH / mvolt meter is calibrated using a standard redox buffer. The milk samples at pH 6.4-7 are previously incubated in a 25 ° C bath. The redox potential is measured after 3 min of stability, and the redox potential is calculated by adding 244.4 mvolt to the displayed redox value.
  • milk samples consisting of 10% of a skimmed milk powder, 1% of yeast extracts and 0.5% of glucose.
  • these milks are heat treated, respectively, for 30 min at 63 ° C. in a hot water bath, for 30 min at 95 ° C. in a hot water bath, for 15 min at 121 ° C in an autoclave, or for 60 min at 121 ° C in an autoclave.
  • These milks are inoculated with the probiotic strain Lactobacillus johnsonii CNCM 1-1225 which was deposited at the Institut Pasteur, 25 rue du do Sheffield Roux, Paris, June 30, 1992.
  • the redox potentials are adjusted at 25 ° C of two MRS artificial media, respectively to about 500 mvolt and -50 mvolt, by adding an appropriate amount of potassium ferricynide or DTT. These two media are inoculated with an inoculum of the strain Lactobacillus johnsonii CNCM 1-1225, they are ferments at aerobic. For aerobic conditions, sterile air bubbles are introduced into the fermentation media. Finally, the number of colonies of bacteria that have grown in these milks is listed.
  • Skimmed pasteurized milk is conventionally inoculated at 115 ° C. for 20 min with 5% of the starter of the strain Lactobacillus johnsonii CNCM 1-1225 and 0.5% of the starter of the strain Streptococcus thermophilus CNCM 1-1421.
  • pH of fermented milks reaches pH 4.5, 0.1% w / v of vitamin C is added, the milks are packed in semi-permeable jars and kept at refrigeration temperatures for 1 , 14 or 28 days, after which the redox potential of the fermented milks is measured and the number of Lactobacillus johnsonii CNCM 1-1225 bacteria which have survived in these fermented milks is listed.
  • Two milks made of 10% of a skimmed milk powder and different, yeast extract concentrations are prepared, these media are heat treated at 11 ° C for 15 min, they are inoculated with 5% of a fresh culture of the Lactobacillus johnsonii CNCM 1-1225 strain, they are incubated at 40 ° C for 1 to 28 days, and the number of lactic acid bacteria having survived these storage conditions is determined.
  • fermented milks stored for 1 to 28 days are analyzed, said milks not comprising yeast extracts.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dairy Products (AREA)
EP97951127A 1996-12-24 1997-11-26 Sauermilchprodukt Withdrawn EP0948262A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP97951127A EP0948262A1 (de) 1996-12-24 1997-11-26 Sauermilchprodukt

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96203708 1996-12-24
EP96203708 1996-12-24
PCT/EP1997/005577 WO1998027824A1 (fr) 1996-12-24 1997-11-26 Produit laitier fermente
EP97951127A EP0948262A1 (de) 1996-12-24 1997-11-26 Sauermilchprodukt

Publications (1)

Publication Number Publication Date
EP0948262A1 true EP0948262A1 (de) 1999-10-13

Family

ID=8224765

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97951127A Withdrawn EP0948262A1 (de) 1996-12-24 1997-11-26 Sauermilchprodukt

Country Status (5)

Country Link
EP (1) EP0948262A1 (de)
AU (1) AU723405B2 (de)
CA (1) CA2274535A1 (de)
IL (1) IL130285A0 (de)
WO (1) WO1998027824A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2424607C (en) * 2000-10-06 2013-01-15 Societe Des Produits Nestle S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
NL1020301C2 (nl) * 2002-04-04 2003-04-11 Winclove Bio Ind B V Werkwijze voor het bereiden van een probiotisch preparaat.
CN1305384C (zh) 2002-04-12 2007-03-21 明治乳业株式会社 能够抵抗幽门螺旋杆菌的乳酪
FR2884113B1 (fr) * 2005-04-06 2007-05-25 Air Liquide Procede par lequel on modifie les qualites hygieniques, physico-chimiques et sensorielles d'un fromage par controle du potentiel redox
FR2891634B1 (fr) * 2005-09-30 2013-12-06 Air Liquide Procede de fabrication d'un produit alimentaire ou biotechnologique mettant en oeuvre une regulation du potentiel redox
EP2248908A1 (de) 2009-05-05 2010-11-10 Eurolactis Group S.A. Aus Eselsmilch isolierte probiotische Mikroorganismen
ITTO20130265A1 (it) * 2013-03-29 2014-09-30 Consiglio Per La Ricerca E La Speri Mentazione In Prodotto caseario e metodo per la produzione di detto prodotto caseario.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1799303A (en) * 1929-04-12 1931-04-07 Walter L Kulp Method of making milk product
US1899817A (en) * 1931-05-23 1933-02-28 Abbotts Dairies Inc Therapeutic milk product and process of making same
GB460972A (en) * 1934-08-04 1937-02-08 Lewis Kempton Mobley Improvements in and relating to bacterial milk products
GB1110978A (en) * 1965-07-06 1968-04-24 Dairy Technics Inc Mixed bacterial concentrates for the fermentation of milk
IT974515B (it) * 1966-07-28 1974-07-10 Kyowa Hakko Kogyo Kk Procedimento per la preparazione di prodotti di latte particolar mente di latte acido ad elevato valore nutritivo
NL9000422A (nl) * 1990-02-21 1991-09-16 Nl Zuivelonderzoek Inst Werkwijze voor de bereiding van een gefermenteerd melkprodukt.
JP2571734B2 (ja) * 1991-08-23 1997-01-16 株式会社ヤクルト本社 乳酸菌飲料

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9827824A1 *

Also Published As

Publication number Publication date
IL130285A0 (en) 2000-06-01
AU723405B2 (en) 2000-08-24
CA2274535A1 (en) 1998-07-02
AU5478998A (en) 1998-07-17
WO1998027824A1 (fr) 1998-07-02

Similar Documents

Publication Publication Date Title
Champagne et al. Challenges in the addition of probiotic cultures to foods
FR2895877A1 (fr) Poudre de lait fermente ou yaourt a haute densite en ferments lactiques
EP1903881B1 (de) Verfahren zur herstellung von fermentierten lebensmittelprodukten mit probiotischen stämmen
Bennani et al. Characterization and identification of lactic acid bacteria isolated from Moroccan raw cow’s milk
US11981890B2 (en) Method for preparing cultures of lactic acid bacteria
EP2040560B1 (de) Cysteingranulate und ihre verwendung als wachstumsstimulanzien für bifidobaceterium animalis lactis
CA2664895C (fr) Utilisation de la gomme arabique pour ameliorer la croissance et la survie des bifidobacteries.
EP1474002B1 (de) Verfahren zur herstellung von sauermilchprodukten mit enzymen bakteriellen ursprungs
EP0948262A1 (de) Sauermilchprodukt
Madureira et al. Incorporation and survival of probiotic bacteria in whey cheese matrices
EP1624761B1 (de) Verfahren und inoculum zur ansäuernden milchsäuregärung
EP1320580B1 (de) Aktivator für eine milchsäurebakterielle starterkultur, und verhfahren zur herstellung eines milchproduktes unter benützung dieses aktivators
EP1986502B1 (de) Zusammensetzung und verfahren für die aromatisierung von milchprodukten, milchsäurebakteriumstamm, verwendung der zusammensetzung bzw. des stamms
Nofiani et al. Characteristics of Lactic Acid Bacteria isolated from traditional fermented fish
EP0949870B1 (de) Quark
Kilara et al. Lactic fermentations of dairy foods and their biological significance
FR2656799A1 (fr) Procede d'obtention d'un levain bacterien pour la fabrication d'un produit dietetique a effet curatif.
RU2132615C1 (ru) Способ получения биологически активной пищевой добавки
WO2023166156A1 (en) Method for preparing cultures of lactic acid bacteria, products and culture media therefore
BE780586Q (fr) Fabrication de produit a saveur de fromage
FR2705015A1 (fr) Produits du type fromages frais et leur procédé d'obtention.
FR2814469A1 (fr) Activateur pour ferment a base de bacteries lactiques
FR2992524A1 (fr) Concentre de jus de carotte fermente avec un gout fruite

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990726

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20021009

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030217